
Pfizer Ltd. (PFIZER) Share Price falls to a fresh 52-week low
Updated: 16 Sept 2026 • 10:51 am
Posted by:

Pfizer Ltd. Share Price opened lower and moved to a fresh 52-week low at Rs 3,962 before recovering part of the gap to Rs 4,008.50, down 0.81% from the previous close of Rs 4,041.35. The stock’s market capitalisation stood at Rs 18,582.96 crore. The price event is relevant because the session marked a new yearly low, but the supplied data does not establish a company-specific catalyst. For readers tracking Pfizer Ltd. Share Price today, the move is a verified price event with clear benchmark data on valuation, profitability and sector context. Univest has captured the event as a fresh 52-week low, and the numbers allow a direct view of the stock’s current positioning versus its own recent range and the broader pharmaceuticals universe.
In short, Pfizer Ltd. Stock News today is about a fresh one-year low, not a narrative about a confirmed trigger. The stock moved from an opening level of Rs 4,076.75 to an intraday low of Rs 3,962, exactly matching the 52-week low, and finished only modestly above that level. Univest notes the event as part of the latest Pfizer Ltd. Share Price update, with the session defined by a lower close than the prior day and a turnover of Rs 0.21 crore.
Pfizer Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,008.5 |
| Previous Close | Rs 4,041.35 |
| Today's Move | Rs -32.85 (-0.81%) |
| Open | Rs 4,076.75 |
| High | Rs 4,076.75 |
| Low | Rs 3,962 |
| Turnover | Rs 0.21 crore |
| Market Capitalisation | Rs 18,582.96 crore |
Pfizer Ltd. (PFIZER) traded at Rs 4,008.5. versus the previous close of Rs 4,041.35, a fall of 0.81%. The stock opened at Rs 4,076.75, reached Rs 4,076.75, touched Rs 3,962.
Pfizer Ltd. Share Price today reflects a clear fresh-low session. The stock closed at Rs 4,008.50 versus the previous close of Rs 4,041.35, a decline of Rs 32.85 or 0.81%. The day opened at Rs 4,076.75, matched the session high at the same level, and then slipped to Rs 3,962, which is also the fresh 52-week low and the day’s low. That means the lowest price printed in the session was Rs 46.50 below the open and Rs 79.85 below the high.
Turnover stood at Rs 0.21 crore, and market capitalisation was Rs 18,582.96 crore. On a simple percentage basis, the close of Rs 4,008.50 sat about 1.17% above the 52-week low of Rs 3,962, so the stock ended near the bottom of its recent range. For investors scanning Pfizer Ltd. Stock News or Pfizer Ltd. Share News, the core fact is straightforward: the stock set a new one-year low in the session and did not recover enough to negate that event. Univest is tracking this as a fresh 52-week low in Pfizer Ltd. Share Price today.
This price action also keeps Pfizer Ltd. Share Price in focus for stock market today searches and for investors comparing stocks in news across healthcare counters. The session’s shape, the fresh 52-week trough and the market capitalisation together define the day’s headline. The next step is to read the valuation and business metrics that sit behind the move.
Pfizer Ltd. (PFIZER) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,582.96 crore |
| P/E Ratio | 25.15x |
| P/B Ratio | 4.19x |
| ROE | 17.16% |
| ROCE | 23.39% |
| EPS | Rs 160.7 |
| Book Value Per Share | Rs 963.41 |
| Dividend Yield | 1.86% |
Pfizer Ltd. (PFIZER) fundamental metrics show P/E 25.15x, P/B 4.19x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.
Pfizer Ltd. has a market capitalisation of Rs 18582.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.15x, P/B at 4.19x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.86%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.05x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.15x |
| Benchmark Median P/E | 32.05x |
| Benchmark Average P/E | 48.12x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 4.19x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 17.16% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 23.39% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 18,582.96 crore |
| Benchmark Median Market Cap | Rs 745.58 crore |
Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Pfizer Ltd. (PFIZER) has a P/E ratio of 25.15x, which is below the benchmark median of 32.05x, a difference of -21.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.74%, a difference of +46.17%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.63%, a difference of +71.61%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Eris Lifesciences Ltd. | ERIS | 18,805.75 | 28.22 | 4.51 | 19.23 | 14.47 |
| Shilpa Medicare Ltd. | SHILPAMED | 18,812.04 | 59.98 | 6.64 | 9.82 | 11.43 |
| Suven Pharmaceuticals Ltd. | COHANCE | 16,834.28 | 152.56 | 4.21 | 4.02 | 6.12 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 16,733.38 | 98.65 | 18.51 | 23.02 | 31.24 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,557.57 | 27.46 | 4.75 | 18.41 | 24.61 |
Pfizer Ltd. (PFIZER) has a P/E ratio of 25.15x compared with the displayed peer median of 59.98x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 18,582.96 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Pfizer Ltd.
- Pfizer Ltd. Share Price fell 0.81% to Rs 4,008.50 after touching a fresh 52-week low of Rs 3,962.
- The stock’s market capitalisation is Rs 18,582.96 crore, which places Pfizer Ltd. within the supplied healthcare comparison set.
- P/E is 25.15, P/B is 4.19, ROE is 17.16% and ROCE is 23.39% in the latest available figures.
- Revenue rose to Rs 6,531.7 crore in Jun 2026 and net profit rose to Rs 2,044.7 crore in Jun 2026.
- Pfizer Ltd. Share Price trades against a sector benchmark of 199 same-industry companies with a P/E median of 32.05.
About Pfizer Ltd.
Pfizer Ltd. is classified in Healthcare and Pharmaceuticals & Drugs. The supplied company financials show revenue and net profit data across recent quarters, along with return ratios, EPS, book value and dividend yield. That is the factual base behind Pfizer Ltd. Share Price and Pfizer Ltd. Company News coverage on Univest. The company’s market cap, valuation multiples and sector placement help readers read the stock as part of the broader Indian Stock Market rather than as a standalone price print.
For readers following Pfizer Ltd. Latest News, the company profile is best understood through the disclosed numbers: market capitalisation, profitability ratios, earnings per share and book value. Univest presents this context so that Pfizer Ltd. Share Price can be viewed with the rest of the financial data attached to the business.
Track Pfizer Ltd. Share Price on Univest
Use Pfizer Ltd. (PFIZER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
You can track Pfizer Ltd. Share Price on Univest for live price updates, stock news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest brings the price event, valuation metrics and sector comparison together in one place so readers can monitor Pfizer Ltd. Share Price Today alongside other healthcare stock updates.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Pfizer Ltd. Share Price fall today?
Ans. Pfizer Ltd. Share Price fell 0.81% to Rs 4,008.50 and touched Rs 3,962, a fresh 52-week low. The supplied data confirms the price event, but it does not establish a company-specific catalyst.
What is the fresh 52-week low for Pfizer Ltd. Share Price?
Ans. The fresh 52-week low for Pfizer Ltd. Share Price is Rs 3,962. That level was also the day’s low, while the stock opened at Rs 4,076.75 and closed at Rs 4,008.50.
What is the market capitalisation of Pfizer Ltd.?
Ans. Pfizer Ltd. has a market capitalisation of Rs 18,582.96 crore. This places the company well above the same-industry median market cap of Rs 745.58 crore in the supplied benchmark set.
How does Pfizer Ltd. compare with sector benchmarks?
Ans. Pfizer Ltd. trades below the same-industry P/E median of 32.05 and above the P/B median of 2.96. Its ROE and ROCE are both above the benchmark medians, which gives useful sector context.
Which peers are closest to Pfizer Ltd. by market cap?
Ans. Eris Lifesciences and Shilpa Medicare are closest by market capitalisation, both near Rs 18,800 crore. Pfizer Ltd. also compares with Suven Pharmaceuticals, Astrazeneca Pharma India and Glenmark Life Sciences in the supplied peer set.
What did Pfizer Ltd. report in revenue and profit?
Ans. Revenue increased to Rs 6,531.7 crore in Jun 2026 from Rs 6,030.5 crore in Jun 2025. Net profit rose to Rs 2,044.7 crore in Jun 2026 from Rs 1,917.5 crore a year earlier.
What sector and industry does Pfizer Ltd. belong to?
Ans. Pfizer Ltd. belongs to Healthcare and the Pharmaceuticals & Drugs industry. The supplied sector snapshot compares it against 199 same-industry companies and 286 same-sector companies. The stock belongs to the Healthcare sector.
Recent Articles

Syrma SGS Technology (SYRMA) Share Price Falls 2.54% Today
16 September 2026

IFCI (IFCI) Share Price Falls 2.6% Today to Rs 74.96
16 September 2026

Craftsman Automation (CRAFTSMAN) Share Price falls 2.65% today; stock news, valuation and sector context
16 September 2026

Multi Commodity Exchange Of India (MCX): MCX Share Price Falls 2.65%: What Dragged the Stock Today
16 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Syrma SGS Technology (SYRMA) Share Price Falls 2.54% Today
IFCI (IFCI) Share Price Falls 2.6% Today to Rs 74.96
Craftsman Automation (CRAFTSMAN) Share Price falls 2.65% today; stock news, valuation and sector context
Multi Commodity Exchange Of India (MCX): MCX Share Price Falls 2.65%: What Dragged the Stock Today
Laurus Labs (LAURUSLABS) Share Price Falls 2.67% to Rs 1,871.60
Popular this week
NIACL Share Price Falls 2.8% as The New India Assurance Company (NIACL) Declines to Rs 180.6

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





